ArticleCancer management and research2025
Fear of Cancer Recurrence and Its Associated Factors in Bladder Cancer Patients of Different Age Stages: A Cross-Sectional Study.
Article in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- The Burden of Worry: Fear of Cancer Recurrence Across Bladder Cancer Survivorship Phases-A Cross-Sectional Analysis.Journal of clinical medicine · 2026Article
- A nurse-led cross-sectional latent profile analysis of fear of cancer recurrence in patients with non-muscle-invasive bladder cancer.Medicine · 2026Article
- Dyadic family hardiness and coping styles on fear of cancer recurrence in adolescent malignant bone tumor patients and caregivers.Scientific reports · 2026Article
- Knowledge, attitudes, and practices related to health management among patients receiving intravesical instillation.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the level of fear of cancer recurrence (FCR) in bladder cancer patients across different age groups and to identify associated sociodemographic, clinical, and psychosocial factors. This study aims to provide an evidence base for developing age-specific psychological interventions. Methods: A cross-sectional survey was conducted among 322 bladder cancer patients primarily diagnosed with non-muscle invasive bladder cancer (NMIBC) at Hebei General Hospital between January 2020 and December 2022. Patients were categorized into a younger group (18-59 years) and an older group (≥60 years). Data were collected using a general information questionnaire, the Fear of Progression Questionnaire-Short Form (FoP-Q-SF), the Social Support Rating Scale (SSRS), and the Simplified Coping Style Questionnaire (SCSQ). Descriptive statistics, t-tests, ANOVA, Pearson correlation, and multiple linear regression analyses were performed. Results: The mean FCR scores were significantly higher in the younger group (33.46 ± 7.62) compared to the older group (28.93 ± 8.58) (P<0.001). Multiple linear regression analysis (R²=0.500, F=31.075, P<0.001) identified several significant predictors of FCR: younger age (β=-0.100, P=0.022), lower per capita monthly family income (β=-0.171, P<0.001), advanced tumor TNM stage (β=0.207, P<0.001), poorer doctor-patient communication (β=0.112 for "General" vs "Very Satisfied", P=0.013), more tumor recurrences (β=0.100, P=0.023), less use of positive coping strategies (β=-0.100, P=0.029), more use of negative coping strategies (β=0.241, P<0.001), and lower social support (β=-0.232, P<0.001). Conclusion: Bladder cancer patients experience considerable FCR, with younger patients exhibiting significantly higher levels than older patients. Factors such as age, socioeconomic status, disease severity, communication, coping styles, and social support are crucial determinants of FCR. Early identification of these factors and the implementation of tailored, age-appropriate interventions are recommended to alleviate FCR in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.